Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

RLMD

Relmada Therapeutics Inc

May 29 • 04:00PM ET

7.21

-0.04 -0.55 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: AXSM KYMR RYTM INCY NUVL BMRN NBIX VKTX KRYS MDGL

| Held by: VTI VXF PSIL ITOT ONEQ PRFZ AVUS AVSC IBRN

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.11	Insider Own	12.21%	Shs Outstand	104.89M	Perf Week	0.00%
Market Cap	756.26M	Forward P/E	-	EPS next Y	-0.96	Insider Trans	0.31%	Shs Float	92.08M	Perf Month	-2.17%
Enterprise Value	522.30M	PEG	-	EPS next Q	-0.19	Inst Own	71.10%	Short Float	5.96%	Perf Quarter	58.11%
Income	-58.88M	P/S	-	EPS this Y	44.83%	Inst Trans	40.91%	Short Ratio	2.91	Perf Half Y	69.25%
Sales	0.00M	P/B	3.46	EPS next Y	-19.75%	ROA	-44.77%	Short Interest	5.49M	Perf YTD	49.28%
Book/sh	2.09	P/C	3.23	EPS next 5Y	12.24%	ROE	-48.83%	52W High	8.00 -9.87%	Perf Year	899.03%
Cash/sh	2.23	P/FCF	-	EPS past 3/5Y	35.03% 17.54%	ROIC	-26.92%	52W Low	0.52 1286.54%	Perf 3Y	145.24%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.01% 6.25%	Perf 5Y	-79.16%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	55.59%	Oper. Margin	-	ATR (14)	0.42	Perf 10Y	-43.14%
Dividend Ex-Date	-	Quick Ratio	18.26	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	51.27	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	18.26	EPS Q/Q	61.90%	SMA20	-0.76%	Beta	0.39	Target Price	12.80
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	1.95%	Rel Volume	0.50	Prev Close	7.25
Employees	17	LT Debt/Eq	0.00	Earnings	May 12 AMC	SMA200	71.20%	Avg Volume	1.88M	Price	7.21
IPO	Jun 20, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-9.84% -	Trades		Volume	944,037	Change	-0.55%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)